Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P040043/S149

GORE TAG Conformable Thoracic Endoprosthesis

W. L. Gore & Associates, Inc. · Decision date Mar 9, 2026

FDA DECISIONP040043/S149

What did the FDA decide?

FDA records P040043/S149 as a supplement to PMA P040043, with the supplement type “30-Day Notice”. The recorded decision is OK30 (30-day notice), dated Mar 9, 2026.

FDA approval order statement

changes to the manufacturing inspection sampling plan for GORE TAG Thoracic Endoprosthesis, the GORE TAG Conformable Thoracic Stent Graft with ACTIVE CONTROL System, and GORE TAG Thoracic Branch Endoprosthesis
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
Cardiovascular
Decision date
Mar 9, 2026
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record

Regulatory record facts

Identifier
P040043/S149
Regulatory pathway
PMA supplement
Product code
MIH
Decision code
OK30
Decision date
Mar 9, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT.

Product code
MIH
FDA device class
3

Review the original FDA PMA listing for the original approval scope and linked supplements.

FDA decision timeline

  1. P040043/S143 · Related supplement

    GORE TAG Conformable Thoracic Endoprosthesis

  2. P040043/S144 · Related supplement

    GORE TAG Conformable Thoracic Stent Graft with ACTIVE CONTROL System (CMDS) 00733132646890; 00733132646906; 007331326

  3. P040043/S145 · Related supplement

    Conformable GORE TAG Thoracic Endoprosthesis

  4. P040043/S146 · Related supplement

    GORE TAG Conformable Thoracic Endoprosthesis

  5. P040043/S147 · Related supplement

    GORE TAG Conformable Thoracic Endoprosthesis

  6. P040043/S149 received

    Application receipt date recorded by FDA.

  7. P040043/S148 · Related supplement

    GORE TAG Conformable Thoracic Stent Graft with ACTIVE CONTROL System

  8. P040043/S149 · FDA decision

    30-Day Notice

Timeline entries are records held by MedtechLedger for P040043. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P040043

Explore the linked device profile

Other records with product code MIH

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

W. L. Gore & Associates, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
3450 Kiltie Ln., P.O. Box 2400, Flagstaff, AZ, 86003

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records